Methods for preventing and treating microbial infections by modulating transcription factors

Details for Australian Patent Application No. 2012202095 (hide)

Owner Paratek Pharmaceuticals, Inc.

Inventors Alekshun, Michael N.; Levy, Stuart B.

Agent Watermark

Pub. Number AU-A-2012202095

Parent 2009213078

Filing date 12 April 2012

Wipo publication date 3 May 2012

International Classifications

A61K 31/4184 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 38/02 (2006.01) Medicinal preparations containing peptides - Peptides of undefined number of amino acids

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12Q 1/18 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Testing for antimicrobial activity of a material

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

26 April 2012 Complete Application Filed

3 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202095

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202096-Radio link and handover failure handling

2012202094-Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins